247 related articles for article (PubMed ID: 36098712)
41. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
[TBL] [Abstract][Full Text] [Related]
42. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
[TBL] [Abstract][Full Text] [Related]
43. Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma.
Lin P; Zhong XZ; Wang XD; Li JJ; Zhao RQ; He Y; Jiang YQ; Huang XW; Chen G; He Y; Yang H
Oncol Rep; 2018 Dec; 40(6):3189-3198. PubMed ID: 30272356
[TBL] [Abstract][Full Text] [Related]
44. A Comprehensive Repertoire of Transfer RNA-Derived Fragments and Their Regulatory Networks in Colorectal Cancer.
Wang X; Zhang Y; Ghareeb WM; Lin S; Lu X; Huang Y; Huang S; Xu Z; Chi P
J Comput Biol; 2020 Dec; 27(12):1644-1655. PubMed ID: 32392430
[TBL] [Abstract][Full Text] [Related]
45. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
46. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
[TBL] [Abstract][Full Text] [Related]
47. Potential mechanism of circRNA_000585 in cholangiocarcinoma.
Yi F; Xin L; Feng L
J Int Med Res; 2021 Jun; 49(6):3000605211024501. PubMed ID: 34182814
[TBL] [Abstract][Full Text] [Related]
48. Expression profiles and function prediction of tRNA-derived fragments in glioma.
Wei D; Niu B; Zhai B; Liu XB; Yao YL; Liang CC; Wang P
BMC Cancer; 2023 Oct; 23(1):1015. PubMed ID: 37864150
[TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
50. Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and
Yao Y; Jiao D; Liu Z; Chen J; Zhou X; Li Z; Li J; Han X
Biomed Res Int; 2020; 2020():5976127. PubMed ID: 33490245
[TBL] [Abstract][Full Text] [Related]
51. Dysregulation of tRNA-derived small RNAs and their potential roles in lupus nephritis.
Liang Y; Zhang J; Qiu W; Chen B; Zhou Y; Chen X; Shentu Y; Zhang H; Bai Y; Chen C
Lupus; 2021 Dec; 30(14):2248-2255. PubMed ID: 34923866
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
53. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
54. Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
Boonmars T; Wu Z; Boonjaruspinyo S; Puapairoj A; Kaewsamut B; Nagano I; Pinlaor S; Yongvanit P; Wonkchalee O; Juasook A; Sudsarn P; Srisawangwong T
Pathol Oncol Res; 2011 Jun; 17(2):219-27. PubMed ID: 20853076
[TBL] [Abstract][Full Text] [Related]
55. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
57. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
[TBL] [Abstract][Full Text] [Related]
58. The potential role of differentially expressed tRNA-derived fragments in high glucose-induced podocytes.
Zhang Z; Qiao Y; Ji J; Huang C; Shi H; Gan W; Zhang A
Ren Fail; 2024 Dec; 46(1):2318413. PubMed ID: 38369750
[TBL] [Abstract][Full Text] [Related]
59. Systematic analysis of tRNA-derived small RNAs reveals therapeutic targets of Xuefu Zhuyu decoction in the cortexes of experimental traumatic brain injury.
Yang ZY; Tang T; Li PF; Li XX; Wu Y; Feng DD; Hu MR; Dai F; Zheng F; Zhang W; Wang Y
Phytomedicine; 2022 Jul; 102():154168. PubMed ID: 35623157
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of microRNA-203 in cholangiocarcinoma.
Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
